Eiger BioPharmaceuticals Inc
NASDAQ:EIGR 3:59:53 PM EDT
Debt Financing / Related
Eiger Biopharmaceuticals Enters Into $75M Term Loan Agreement And $5M Stock Purchase Agreement With Innovatus Capital Partners To Refinance Existing Debt Facility And Further Strengthen Cash Pos
Published: 06/07/2022 20:32 GMT
Eiger BioPharmaceuticals Inc (EIGR) - Eiger Biopharmaceuticals Enters Into $75m Term Loan Agreement and $5m Stock Purchase Agreement With Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Position Ahead of Key Milestones.
Eiger Biopharmaceuticals - Company Expects Its Cash, Cash Equivalents, and Total Investments to Fund Planned Operations Through 2024.
Eiger Biopharmaceuticals - Company Expects Its Cash, Cash Equivalents, and Total Investments to Fund Planned Operations Through 2024.